aTyr Pharma, Inc. (LIFE)
Chart Events
Performance Outlook
| Previous Close | 2.1100 |
| Open | 2.1300 |
| Bid | 2.0900 x 2900 |
| Ask | 2.1000 x 800 |
| Day's Range | 2.0500 - 2.2400 |
| 52 Week Range | 1.8150 - 5.9700 |
| Volume | |
| Avg. Volume | 282,401 |
| Market Cap | 60.876M |
| Beta (5Y Monthly) | 1.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7710 |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.17 |
- GlobeNewswire
aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases
Paper highlights efzofitimod as a first-in-class biologic with significant anti-inflammatory propertiesSAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the publication of a review article, titled, “Efzofitimod: a novel anti-inflammatory agent for sarcoidosis,” in the peer-reviewed journal Sarcoidosis, Vasculit
- TipRanks
2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon
Penny stocks are controversial, to say the least. When it comes to these under $5 per share investment opportunities, Wall Street observers usually either love them or hate them. The penny stock-averse point out that while the bargain price tag is tempting, there could be a reason shares are trading at such low levels like poor fundamentals or insurmountable headwinds. However, the other side of the coin has merit as well. Naturally, with these cheap tickers, you get more bang for your buck in t
- Simply Wall St.
Here's Why We're Watching aTyr Pharma's (NASDAQ:LIFE) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
